| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PPAR alpha | 28 | 2023 | 45 | 13.820 |
Why?
|
| Mice | 107 | 2023 | 1228 | 9.160 |
Why?
|
| Animals | 152 | 2023 | 3255 | 9.110 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 25 | 2023 | 50 | 8.250 |
Why?
|
| Astrocytes | 39 | 2021 | 126 | 7.890 |
Why?
|
| Up-Regulation | 29 | 2023 | 141 | 7.120 |
Why?
|
| Microglia | 33 | 2023 | 108 | 6.620 |
Why?
|
| Multiple Sclerosis | 21 | 2023 | 77 | 6.250 |
Why?
|
| Neurons | 30 | 2020 | 273 | 6.080 |
Why?
|
| Dopaminergic Neurons | 12 | 2023 | 39 | 5.690 |
Why?
|
| Gemfibrozil | 17 | 2023 | 29 | 5.590 |
Why?
|
| Sodium Benzoate | 12 | 2021 | 15 | 5.160 |
Why?
|
| Aspirin | 9 | 2019 | 48 | 4.930 |
Why?
|
| Hippocampus | 16 | 2023 | 197 | 4.920 |
Why?
|
| Alzheimer Disease | 20 | 2023 | 1319 | 4.490 |
Why?
|
| Disease Models, Animal | 34 | 2023 | 517 | 4.410 |
Why?
|
| Mice, Inbred C57BL | 40 | 2023 | 363 | 4.280 |
Why?
|
| Cinnamomum zeylanicum | 12 | 2021 | 16 | 4.190 |
Why?
|
| Interleukin-12 Subunit p40 | 12 | 2022 | 20 | 3.850 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 10 | 2019 | 86 | 3.820 |
Why?
|
| Neuroprotective Agents | 9 | 2021 | 43 | 3.740 |
Why?
|
| Cells, Cultured | 59 | 2021 | 463 | 3.700 |
Why?
|
| Substantia Nigra | 13 | 2022 | 101 | 3.610 |
Why?
|
| Parkinsonian Disorders | 9 | 2021 | 164 | 3.450 |
Why?
|
| NF-kappa B | 33 | 2023 | 99 | 3.430 |
Why?
|
| Sodium Chloride | 9 | 2020 | 29 | 3.360 |
Why?
|
| Signal Transduction | 27 | 2021 | 390 | 3.210 |
Why?
|
| Parkinson Disease | 14 | 2023 | 591 | 3.180 |
Why?
|
| Peptides | 8 | 2021 | 89 | 2.940 |
Why?
|
| Gene Expression Regulation | 19 | 2021 | 231 | 2.890 |
Why?
|
| Nitric Oxide Synthase Type II | 29 | 2014 | 62 | 2.780 |
Why?
|
| Hypolipidemic Agents | 9 | 2023 | 23 | 2.740 |
Why?
|
| Memory | 9 | 2021 | 213 | 2.690 |
Why?
|
| Interleukin-12 | 12 | 2023 | 34 | 2.660 |
Why?
|
| Cytokines | 26 | 2023 | 202 | 2.640 |
Why?
|
| Nitric Oxide | 22 | 2014 | 72 | 2.600 |
Why?
|
| Food Additives | 5 | 2023 | 6 | 2.590 |
Why?
|
| Neurodegenerative Diseases | 10 | 2019 | 95 | 2.560 |
Why?
|
| Neuroglia | 18 | 2023 | 39 | 2.540 |
Why?
|
| alpha-Synuclein | 7 | 2022 | 103 | 2.520 |
Why?
|
| Nitric Oxide Synthase | 19 | 2005 | 42 | 2.490 |
Why?
|
| Brain | 20 | 2023 | 1202 | 2.380 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 5 | 2023 | 8 | 2.360 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 14 | 2019 | 28 | 2.280 |
Why?
|
| Inflammation | 16 | 2023 | 226 | 2.250 |
Why?
|
| Oligodendroglia | 9 | 2017 | 27 | 2.190 |
Why?
|
| Humans | 93 | 2023 | 22823 | 2.190 |
Why?
|
| Plaque, Amyloid | 6 | 2023 | 85 | 2.150 |
Why?
|
| Mice, Transgenic | 18 | 2023 | 171 | 2.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 23 | 2017 | 164 | 2.110 |
Why?
|
| T-Lymphocytes, Regulatory | 7 | 2019 | 30 | 2.080 |
Why?
|
| Amyloid beta-Peptides | 10 | 2023 | 198 | 2.070 |
Why?
|
| Peptide Fragments | 9 | 2021 | 56 | 2.030 |
Why?
|
| Food Preservatives | 5 | 2021 | 8 | 2.020 |
Why?
|
| Lysosomes | 6 | 2018 | 20 | 1.970 |
Why?
|
| Apoptosis | 14 | 2020 | 180 | 1.930 |
Why?
|
| Neuronal Plasticity | 6 | 2019 | 38 | 1.880 |
Why?
|
| Myelin Basic Protein | 11 | 2013 | 20 | 1.810 |
Why?
|
| Cinnamates | 3 | 2019 | 8 | 1.740 |
Why?
|
| Chemokine CCL5 | 4 | 2019 | 9 | 1.700 |
Why?
|
| Promoter Regions, Genetic | 12 | 2021 | 81 | 1.690 |
Why?
|
| PPAR-beta | 4 | 2023 | 10 | 1.670 |
Why?
|
| Mice, Knockout | 16 | 2021 | 276 | 1.650 |
Why?
|
| Adoptive Transfer | 7 | 2019 | 30 | 1.630 |
Why?
|
| Th17 Cells | 7 | 2020 | 23 | 1.600 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2023 | 14 | 1.590 |
Why?
|
| Receptors, Interleukin-12 | 6 | 2020 | 13 | 1.530 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2021 | 67 | 1.510 |
Why?
|
| Myelin Sheath | 6 | 2017 | 22 | 1.450 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 4 | 2019 | 5 | 1.400 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 3 | 2021 | 23 | 1.390 |
Why?
|
| MPTP Poisoning | 4 | 2019 | 13 | 1.380 |
Why?
|
| Interleukin-23 | 6 | 2023 | 14 | 1.340 |
Why?
|
| Sphingomyelin Phosphodiesterase | 6 | 2010 | 9 | 1.330 |
Why?
|
| T-Lymphocytes | 9 | 2010 | 94 | 1.320 |
Why?
|
| Macrophages, Peritoneal | 9 | 2014 | 16 | 1.290 |
Why?
|
| Oxygen | 4 | 2014 | 54 | 1.260 |
Why?
|
| Male | 37 | 2021 | 12400 | 1.260 |
Why?
|
| Female | 35 | 2022 | 12904 | 1.250 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2020 | 35 | 1.250 |
Why?
|
| Toll-Like Receptor 2 | 4 | 2023 | 31 | 1.230 |
Why?
|
| Lipopolysaccharides | 19 | 2018 | 82 | 1.230 |
Why?
|
| Antibodies, Monoclonal | 3 | 2022 | 164 | 1.230 |
Why?
|
| Dopamine | 4 | 2018 | 77 | 1.230 |
Why?
|
| Corpus Striatum | 3 | 2019 | 63 | 1.230 |
Why?
|
| Oxidative Stress | 8 | 2023 | 81 | 1.190 |
Why?
|
| Cell Line | 17 | 2019 | 247 | 1.180 |
Why?
|
| Interferon-gamma | 13 | 2022 | 72 | 1.160 |
Why?
|
| Cerebral Cortex | 5 | 2021 | 125 | 1.160 |
Why?
|
| Forkhead Transcription Factors | 4 | 2016 | 18 | 1.140 |
Why?
|
| RNA, Messenger | 15 | 2023 | 271 | 1.130 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 3 | 2019 | 5 | 1.120 |
Why?
|
| Aminopeptidases | 3 | 2019 | 6 | 1.120 |
Why?
|
| Serine Proteases | 3 | 2019 | 6 | 1.120 |
Why?
|
| Administration, Oral | 9 | 2021 | 97 | 1.090 |
Why?
|
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 15 | 1.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 13 | 2015 | 129 | 1.050 |
Why?
|
| Plant Extracts | 3 | 2016 | 12 | 1.050 |
Why?
|
| Inflammation Mediators | 9 | 2021 | 58 | 1.040 |
Why?
|
| Myeloid Differentiation Factor 88 | 4 | 2023 | 18 | 1.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2015 | 42 | 1.010 |
Why?
|
| Protein Deglycase DJ-1 | 3 | 2023 | 4 | 0.990 |
Why?
|
| Phosphatidylinositol 3-Kinases | 7 | 2017 | 44 | 0.980 |
Why?
|
| Nootropic Agents | 2 | 2016 | 11 | 0.940 |
Why?
|
| Ceramides | 9 | 2010 | 14 | 0.940 |
Why?
|
| Motor Activity | 9 | 2021 | 267 | 0.930 |
Why?
|
| Learning | 2 | 2016 | 59 | 0.920 |
Why?
|
| Nerve Tissue Proteins | 4 | 2014 | 126 | 0.880 |
Why?
|
| Ciliary Neurotrophic Factor | 2 | 2015 | 8 | 0.880 |
Why?
|
| Dose-Response Relationship, Drug | 14 | 2018 | 312 | 0.870 |
Why?
|
| Microbodies | 12 | 1998 | 12 | 0.870 |
Why?
|
| Th1 Cells | 6 | 2019 | 23 | 0.860 |
Why?
|
| Protein Binding | 7 | 2021 | 106 | 0.860 |
Why?
|
| Tay-Sachs Disease | 1 | 2023 | 1 | 0.840 |
Why?
|
| Nerve Growth Factors | 2 | 2015 | 32 | 0.840 |
Why?
|
| Adaptive Immunity | 3 | 2022 | 12 | 0.830 |
Why?
|
| Phenylbutyrates | 3 | 2013 | 5 | 0.820 |
Why?
|
| Oleic Acids | 2 | 2021 | 3 | 0.810 |
Why?
|
| Down-Regulation | 7 | 2014 | 84 | 0.810 |
Why?
|
| Rats | 26 | 2013 | 623 | 0.800 |
Why?
|
| Ascorbic Acid | 1 | 2023 | 28 | 0.800 |
Why?
|
| Palmitic Acids | 4 | 2020 | 5 | 0.800 |
Why?
|
| Oncogene Proteins | 2 | 2014 | 6 | 0.790 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2018 | 51 | 0.790 |
Why?
|
| Neostriatum | 2 | 2021 | 13 | 0.780 |
Why?
|
| Enzyme Inhibitors | 16 | 2006 | 113 | 0.780 |
Why?
|
| Simvastatin | 2 | 2015 | 12 | 0.780 |
Why?
|
| Immunosuppressive Agents | 2 | 2019 | 111 | 0.760 |
Why?
|
| Physical Conditioning, Animal | 1 | 2022 | 6 | 0.760 |
Why?
|
| Enzyme Activation | 13 | 2015 | 107 | 0.750 |
Why?
|
| Chemokine CCL11 | 3 | 2017 | 5 | 0.740 |
Why?
|
| Reactive Oxygen Species | 8 | 2015 | 98 | 0.740 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2022 | 18 | 0.730 |
Why?
|
| HIV Envelope Protein gp120 | 5 | 2014 | 14 | 0.730 |
Why?
|
| Primary Cell Culture | 6 | 2021 | 24 | 0.730 |
Why?
|
| Syzygium | 1 | 2021 | 2 | 0.720 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 15 | 0.720 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 111 | 0.700 |
Why?
|
| Organelle Biogenesis | 2 | 2018 | 3 | 0.700 |
Why?
|
| Mitochondria | 5 | 2017 | 52 | 0.700 |
Why?
|
| Interleukin-1 | 12 | 2005 | 44 | 0.690 |
Why?
|
| Flavoring Agents | 1 | 2021 | 1 | 0.690 |
Why?
|
| Benzoates | 1 | 2021 | 5 | 0.690 |
Why?
|
| Macrophages | 6 | 2023 | 88 | 0.690 |
Why?
|
| Huntingtin Protein | 1 | 2021 | 12 | 0.690 |
Why?
|
| Sleep Aids, Pharmaceutical | 1 | 2021 | 1 | 0.690 |
Why?
|
| Motor Cortex | 1 | 2021 | 16 | 0.680 |
Why?
|
| Lung | 1 | 2021 | 138 | 0.680 |
Why?
|
| Antioxidants | 6 | 2012 | 54 | 0.680 |
Why?
|
| Fever | 1 | 2021 | 32 | 0.670 |
Why?
|
| Neurotrophin 3 | 2 | 2013 | 2 | 0.670 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 56 | 0.670 |
Why?
|
| Butyrates | 2 | 2019 | 12 | 0.660 |
Why?
|
| Huntington Disease | 1 | 2021 | 45 | 0.660 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2023 | 7 | 0.660 |
Why?
|
| Lung Diseases | 1 | 2021 | 36 | 0.660 |
Why?
|
| CD11b Antigen | 4 | 2019 | 13 | 0.660 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2023 | 10 | 0.660 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 8 | 0.650 |
Why?
|
| Lipid Metabolism | 3 | 2015 | 34 | 0.650 |
Why?
|
| Heart Diseases | 1 | 2021 | 56 | 0.650 |
Why?
|
| Gene Expression | 6 | 2015 | 175 | 0.640 |
Why?
|
| Phytanic Acid | 8 | 1996 | 8 | 0.640 |
Why?
|
| Gene Editing | 1 | 2019 | 7 | 0.630 |
Why?
|
| Gene Expression Regulation, Enzymologic | 6 | 2012 | 30 | 0.630 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 11 | 0.630 |
Why?
|
| Membrane Proteins | 2 | 2023 | 146 | 0.610 |
Why?
|
| Transcription Factors | 7 | 2021 | 145 | 0.610 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2019 | 10 | 0.610 |
Why?
|
| Betacoronavirus | 1 | 2020 | 64 | 0.610 |
Why?
|
| Antiparkinson Agents | 1 | 2019 | 41 | 0.600 |
Why?
|
| tau Proteins | 2 | 2023 | 145 | 0.600 |
Why?
|
| Cognition | 2 | 2023 | 947 | 0.590 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 9 | 2005 | 15 | 0.590 |
Why?
|
| Interleukin-11 | 1 | 2018 | 5 | 0.590 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2015 | 14 | 0.590 |
Why?
|
| Recovery of Function | 1 | 2020 | 242 | 0.590 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 74 | 0.580 |
Why?
|
| Oxidation-Reduction | 17 | 2005 | 61 | 0.580 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 77 | 0.580 |
Why?
|
| Integrin alpha4beta1 | 3 | 2010 | 5 | 0.580 |
Why?
|
| Nuclear Proteins | 2 | 2016 | 72 | 0.570 |
Why?
|
| HEK293 Cells | 3 | 2023 | 58 | 0.560 |
Why?
|
| Pharmaceutical Solutions | 1 | 2017 | 2 | 0.550 |
Why?
|
| Castration | 3 | 2013 | 4 | 0.550 |
Why?
|
| Fenofibrate | 2 | 2019 | 4 | 0.540 |
Why?
|
| Longevity | 1 | 2017 | 18 | 0.520 |
Why?
|
| RNA, Small Interfering | 5 | 2018 | 73 | 0.520 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2017 | 21 | 0.520 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 6 | 2009 | 34 | 0.520 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2017 | 11 | 0.510 |
Why?
|
| Hydroxybutyrates | 1 | 2016 | 6 | 0.510 |
Why?
|
| Rotarod Performance Test | 3 | 2021 | 7 | 0.510 |
Why?
|
| Repressor Proteins | 2 | 2013 | 32 | 0.510 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 86 | 0.510 |
Why?
|
| Response Elements | 2 | 2013 | 12 | 0.510 |
Why?
|
| STAT6 Transcription Factor | 1 | 2016 | 10 | 0.510 |
Why?
|
| Spatial Learning | 3 | 2023 | 4 | 0.490 |
Why?
|
| Cell Movement | 4 | 2011 | 73 | 0.490 |
Why?
|
| Basal Ganglia | 1 | 2016 | 13 | 0.490 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 81 | 0.480 |
Why?
|
| Immunoblotting | 7 | 2015 | 51 | 0.480 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2009 | 19 | 0.480 |
Why?
|
| Mevalonic Acid | 6 | 2012 | 6 | 0.470 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 227 | 0.470 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2015 | 3 | 0.470 |
Why?
|
| Spinal Cord | 5 | 2015 | 74 | 0.460 |
Why?
|
| Cell Separation | 4 | 2010 | 21 | 0.460 |
Why?
|
| HIV Infections | 1 | 2019 | 430 | 0.460 |
Why?
|
| ADAM Proteins | 1 | 2015 | 41 | 0.460 |
Why?
|
| AIDS Dementia Complex | 2 | 2007 | 38 | 0.450 |
Why?
|
| Mercury | 7 | 1997 | 9 | 0.450 |
Why?
|
| CREB-Binding Protein | 2 | 2018 | 3 | 0.450 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2014 | 38 | 0.450 |
Why?
|
| Nerve Degeneration | 2 | 2019 | 34 | 0.440 |
Why?
|
| Transcriptional Activation | 5 | 2018 | 26 | 0.440 |
Why?
|
| Enzyme Induction | 10 | 2008 | 19 | 0.440 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2012 | 2 | 0.440 |
Why?
|
| Cinnamomum | 1 | 2014 | 1 | 0.440 |
Why?
|
| Synaptic Transmission | 1 | 2014 | 20 | 0.440 |
Why?
|
| Peroxiredoxins | 1 | 2014 | 11 | 0.430 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2010 | 37 | 0.430 |
Why?
|
| Phytotherapy | 1 | 2014 | 10 | 0.430 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 26 | 0.430 |
Why?
|
| Adipose Tissue | 1 | 2015 | 73 | 0.430 |
Why?
|
| Nanotechnology | 1 | 2014 | 4 | 0.430 |
Why?
|
| Interleukin-7 | 1 | 2014 | 13 | 0.430 |
Why?
|
| Superoxide Dismutase | 3 | 2007 | 15 | 0.420 |
Why?
|
| Transcription Factor RelA | 4 | 2007 | 15 | 0.420 |
Why?
|
| Th2 Cells | 3 | 2010 | 15 | 0.420 |
Why?
|
| Memory Disorders | 1 | 2015 | 108 | 0.420 |
Why?
|
| Ankyrin Repeat | 1 | 2013 | 1 | 0.410 |
Why?
|
| Immunologic Factors | 2 | 2011 | 19 | 0.410 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 21 | 0.410 |
Why?
|
| Bacillus | 4 | 1995 | 4 | 0.410 |
Why?
|
| Transfection | 6 | 2018 | 114 | 0.400 |
Why?
|
| Interleukin-6 | 5 | 2021 | 70 | 0.390 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2011 | 7 | 0.390 |
Why?
|
| Fatty Acids | 10 | 2015 | 33 | 0.380 |
Why?
|
| Cell Communication | 2 | 2011 | 21 | 0.380 |
Why?
|
| Protein Multimerization | 2 | 2009 | 13 | 0.380 |
Why?
|
| Transcription, Genetic | 6 | 2013 | 94 | 0.380 |
Why?
|
| Phenylacetates | 3 | 2003 | 5 | 0.370 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2013 | 33 | 0.370 |
Why?
|
| Phosphorylation | 4 | 2017 | 127 | 0.370 |
Why?
|
| I-kappa B Proteins | 2 | 2012 | 10 | 0.370 |
Why?
|
| Disease Progression | 5 | 2017 | 521 | 0.370 |
Why?
|
| Interleukin-1beta | 4 | 2017 | 36 | 0.360 |
Why?
|
| CD40 Antigens | 2 | 2002 | 6 | 0.360 |
Why?
|
| Cell Differentiation | 4 | 2021 | 125 | 0.360 |
Why?
|
| RNA, Double-Stranded | 3 | 2008 | 4 | 0.360 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2022 | 94 | 0.350 |
Why?
|
| Blotting, Western | 5 | 2014 | 122 | 0.340 |
Why?
|
| Cyclic AMP | 3 | 2006 | 31 | 0.330 |
Why?
|
| Sphingolipids | 1 | 2010 | 3 | 0.330 |
Why?
|
| Time Factors | 7 | 2013 | 1258 | 0.330 |
Why?
|
| Integrin beta1 | 1 | 2010 | 4 | 0.330 |
Why?
|
| Organomercury Compounds | 5 | 1997 | 5 | 0.320 |
Why?
|
| Hyperlipidemias | 2 | 2009 | 17 | 0.320 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2014 | 33 | 0.320 |
Why?
|
| Cell Survival | 6 | 2009 | 94 | 0.320 |
Why?
|
| Genes, Dominant | 4 | 2005 | 10 | 0.320 |
Why?
|
| Mice, Inbred Strains | 5 | 2010 | 30 | 0.320 |
Why?
|
| ADAM10 Protein | 2 | 2023 | 3 | 0.310 |
Why?
|
| Liver | 6 | 1997 | 136 | 0.310 |
Why?
|
| Spleen | 3 | 2022 | 28 | 0.310 |
Why?
|
| Macaca mulatta | 3 | 2015 | 56 | 0.310 |
Why?
|
| Aging | 3 | 2018 | 1100 | 0.310 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 162 | 0.300 |
Why?
|
| PPAR gamma | 3 | 2015 | 13 | 0.300 |
Why?
|
| Nervous System Diseases | 2 | 2009 | 99 | 0.300 |
Why?
|
| Central Nervous System | 2 | 2006 | 47 | 0.300 |
Why?
|
| Myelin Proteolipid Protein | 3 | 2016 | 6 | 0.300 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 323 | 0.300 |
Why?
|
| Interleukin-16 | 1 | 2008 | 6 | 0.300 |
Why?
|
| Lymphotoxin-alpha | 1 | 2008 | 2 | 0.300 |
Why?
|
| Interleukin-12 Receptor beta 1 Subunit | 1 | 2008 | 2 | 0.300 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2010 | 53 | 0.290 |
Why?
|
| Hybridomas | 1 | 2008 | 1 | 0.290 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 4 | 2015 | 35 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2014 | 57 | 0.280 |
Why?
|
| Administration, Intranasal | 2 | 2021 | 26 | 0.280 |
Why?
|
| Base Sequence | 3 | 2019 | 98 | 0.280 |
Why?
|
| Clofibric Acid | 2 | 2006 | 2 | 0.280 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2007 | 2 | 0.280 |
Why?
|
| Flow Cytometry | 4 | 2012 | 102 | 0.270 |
Why?
|
| Integrins | 1 | 2007 | 10 | 0.270 |
Why?
|
| NADPH Oxidases | 2 | 2004 | 44 | 0.270 |
Why?
|
| Fetus | 4 | 2013 | 32 | 0.270 |
Why?
|
| eIF-2 Kinase | 2 | 2004 | 4 | 0.260 |
Why?
|
| Plant Bark | 2 | 2019 | 2 | 0.260 |
Why?
|
| Adrenoleukodystrophy | 6 | 1998 | 6 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2006 | 28 | 0.260 |
Why?
|
| Free Radical Scavengers | 2 | 2006 | 7 | 0.260 |
Why?
|
| Sulfonamides | 2 | 2015 | 45 | 0.260 |
Why?
|
| HIV-1 | 2 | 2008 | 202 | 0.260 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2017 | 10 | 0.250 |
Why?
|
| Antibodies, Blocking | 2 | 2016 | 4 | 0.250 |
Why?
|
| Acetylcysteine | 5 | 2005 | 13 | 0.250 |
Why?
|
| Lyases | 4 | 1997 | 7 | 0.250 |
Why?
|
| Mutation | 3 | 2021 | 321 | 0.250 |
Why?
|
| Coenzyme A Ligases | 4 | 1995 | 5 | 0.250 |
Why?
|
| Biological Transport | 4 | 2021 | 37 | 0.250 |
Why?
|
| Bacteria | 4 | 2006 | 61 | 0.250 |
Why?
|
| Gene Products, tat | 2 | 2004 | 4 | 0.250 |
Why?
|
| Neuroimmunomodulation | 1 | 2006 | 7 | 0.250 |
Why?
|
| Histone Acetyltransferases | 1 | 2006 | 4 | 0.250 |
Why?
|
| Histone Deacetylases | 1 | 2006 | 11 | 0.250 |
Why?
|
| Protein Subunits | 2 | 2003 | 15 | 0.250 |
Why?
|
| Synapses | 2 | 2018 | 23 | 0.250 |
Why?
|
| Brain Diseases | 1 | 2006 | 55 | 0.240 |
Why?
|
| Blood-Brain Barrier | 2 | 2016 | 34 | 0.230 |
Why?
|
| Cell Death | 4 | 2013 | 33 | 0.220 |
Why?
|
| Coculture Techniques | 4 | 2019 | 30 | 0.220 |
Why?
|
| Maze Learning | 2 | 2015 | 12 | 0.220 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2019 | 22 | 0.210 |
Why?
|
| Lovastatin | 3 | 1999 | 7 | 0.210 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 3717 | 0.210 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2013 | 15 | 0.210 |
Why?
|
| Retinoid X Receptor alpha | 2 | 2015 | 6 | 0.210 |
Why?
|
| Glycoconjugates | 1 | 2023 | 1 | 0.210 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2023 | 2 | 0.210 |
Why?
|
| Interleukin-2 | 1 | 2023 | 22 | 0.210 |
Why?
|
| Electrophoretic Mobility Shift Assay | 3 | 2010 | 10 | 0.210 |
Why?
|
| Luciferases | 3 | 2014 | 22 | 0.210 |
Why?
|
| Demyelinating Diseases | 2 | 2015 | 12 | 0.210 |
Why?
|
| Water Pollutants, Chemical | 2 | 1995 | 2 | 0.210 |
Why?
|
| Genes, Reporter | 3 | 2014 | 22 | 0.210 |
Why?
|
| Valerates | 1 | 2023 | 2 | 0.200 |
Why?
|
| Hydrogen Peroxide | 5 | 2008 | 37 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 45 | 0.200 |
Why?
|
| Interleukins | 2 | 2019 | 21 | 0.200 |
Why?
|
| Fruit | 1 | 2023 | 23 | 0.200 |
Why?
|
| Muscles | 1 | 2023 | 55 | 0.200 |
Why?
|
| Virus Internalization | 1 | 2023 | 18 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2013 | 314 | 0.200 |
Why?
|
| Tyrosine | 1 | 2003 | 22 | 0.200 |
Why?
|
| Oxidoreductases | 5 | 1997 | 9 | 0.200 |
Why?
|
| Molecular Chaperones | 1 | 2023 | 8 | 0.200 |
Why?
|
| Dimerization | 3 | 2008 | 19 | 0.200 |
Why?
|
| Proteomics | 1 | 2023 | 55 | 0.200 |
Why?
|
| Aged | 4 | 2017 | 7412 | 0.200 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 50 | 0.190 |
Why?
|
| DNA Primers | 3 | 2012 | 49 | 0.190 |
Why?
|
| Antigens, CD | 2 | 2015 | 49 | 0.190 |
Why?
|
| Neutralization Tests | 1 | 2022 | 5 | 0.180 |
Why?
|
| CD40 Ligand | 1 | 2002 | 7 | 0.180 |
Why?
|
| Mice, Inbred NOD | 1 | 2022 | 23 | 0.180 |
Why?
|
| Mice, SCID | 1 | 2022 | 39 | 0.180 |
Why?
|
| Ocimum sanctum | 1 | 2021 | 2 | 0.180 |
Why?
|
| Eugenol | 1 | 2021 | 2 | 0.180 |
Why?
|
| Spices | 1 | 2021 | 2 | 0.180 |
Why?
|
| A549 Cells | 1 | 2021 | 10 | 0.180 |
Why?
|
| Testosterone | 2 | 2013 | 27 | 0.180 |
Why?
|
| Behavior, Animal | 1 | 2021 | 46 | 0.180 |
Why?
|
| Antibodies | 1 | 2002 | 43 | 0.180 |
Why?
|
| Thiocarbamates | 5 | 2005 | 6 | 0.180 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 16 | 0.180 |
Why?
|
| Pyrrolidines | 5 | 2005 | 11 | 0.180 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 3 | 2019 | 5 | 0.180 |
Why?
|
| Locomotion | 1 | 2021 | 20 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2022 | 48 | 0.180 |
Why?
|
| Superoxides | 3 | 2007 | 22 | 0.180 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 31 | 0.180 |
Why?
|
| Calcium | 2 | 2014 | 325 | 0.180 |
Why?
|
| Carrier Proteins | 2 | 2016 | 87 | 0.180 |
Why?
|
| Acute Disease | 2 | 2017 | 162 | 0.170 |
Why?
|
| Multiple System Atrophy | 1 | 2021 | 26 | 0.170 |
Why?
|
| Imidazoles | 2 | 2006 | 61 | 0.170 |
Why?
|
| Benzoic Acid | 1 | 2021 | 1 | 0.170 |
Why?
|
| Cytochrome P-450 CYP2C8 Inhibitors | 1 | 2021 | 2 | 0.170 |
Why?
|
| Ligands | 2 | 2016 | 36 | 0.170 |
Why?
|
| Neutrophil Infiltration | 1 | 2021 | 8 | 0.170 |
Why?
|
| Hand Strength | 1 | 2021 | 49 | 0.170 |
Why?
|
| Lewy Body Disease | 1 | 2021 | 70 | 0.170 |
Why?
|
| Gender Identity | 1 | 2021 | 20 | 0.170 |
Why?
|
| Lymphocyte Activation | 3 | 2019 | 76 | 0.170 |
Why?
|
| Interleukin-13 | 1 | 2000 | 10 | 0.170 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 323 | 0.170 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 57 | 0.170 |
Why?
|
| Interleukin-10 | 1 | 2000 | 18 | 0.170 |
Why?
|
| Antimalarials | 1 | 2020 | 8 | 0.160 |
Why?
|
| Coenzyme A | 3 | 1996 | 3 | 0.160 |
Why?
|
| DNA | 3 | 2007 | 92 | 0.160 |
Why?
|
| Drug Repositioning | 1 | 2020 | 4 | 0.160 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2012 | 7 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2021 | 85 | 0.160 |
Why?
|
| Fibroblasts | 9 | 1999 | 49 | 0.160 |
Why?
|
| Middle Aged | 3 | 2017 | 7873 | 0.160 |
Why?
|
| Adult | 4 | 2020 | 6896 | 0.160 |
Why?
|
| Alkyl and Aryl Transferases | 3 | 2011 | 3 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 75 | 0.160 |
Why?
|
| Myeloid Cells | 1 | 2019 | 8 | 0.160 |
Why?
|
| Peroxisomal Disorders | 2 | 1998 | 2 | 0.160 |
Why?
|
| Sphingosine | 1 | 1999 | 2 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 258 | 0.160 |
Why?
|
| Lewy Bodies | 1 | 2020 | 146 | 0.160 |
Why?
|
| Isoquinolines | 2 | 2015 | 12 | 0.150 |
Why?
|
| Pars Compacta | 1 | 2019 | 1 | 0.150 |
Why?
|
| Biotransformation | 1 | 2019 | 5 | 0.150 |
Why?
|
| Exploratory Behavior | 1 | 2019 | 9 | 0.150 |
Why?
|
| Skin | 6 | 1999 | 118 | 0.150 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 27 | 0.150 |
Why?
|
| Refsum Disease | 2 | 1996 | 2 | 0.150 |
Why?
|
| Cricetinae | 2 | 2009 | 34 | 0.150 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 19 | 0.150 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2018 | 5 | 0.150 |
Why?
|
| Docosahexaenoic Acids | 1 | 2018 | 7 | 0.150 |
Why?
|
| Rotenone | 1 | 2018 | 6 | 0.150 |
Why?
|
| Lysophosphatidylcholines | 1 | 2018 | 8 | 0.150 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2009 | 16 | 0.150 |
Why?
|
| Androstadienes | 3 | 2007 | 8 | 0.150 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 26 | 0.150 |
Why?
|
| Pandemics | 1 | 2020 | 201 | 0.140 |
Why?
|
| Channelopathies | 1 | 2018 | 5 | 0.140 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2018 | 8 | 0.140 |
Why?
|
| Sleep | 1 | 2021 | 267 | 0.140 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2018 | 9 | 0.140 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1998 | 4 | 0.140 |
Why?
|
| Isoenzymes | 1 | 1998 | 48 | 0.140 |
Why?
|
| Gait | 1 | 2021 | 381 | 0.140 |
Why?
|
| Sulfhydryl Compounds | 2 | 2005 | 3 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 24 | 0.140 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 33 | 0.140 |
Why?
|
| Water Microbiology | 2 | 1995 | 9 | 0.140 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 25 | 0.140 |
Why?
|
| X Chromosome | 4 | 1998 | 8 | 0.140 |
Why?
|
| Anticholesteremic Agents | 1 | 1997 | 14 | 0.140 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 9 | 0.140 |
Why?
|
| Diet | 1 | 2018 | 178 | 0.130 |
Why?
|
| Prostate | 1 | 2017 | 30 | 0.130 |
Why?
|
| bcl-Associated Death Protein | 1 | 2017 | 1 | 0.130 |
Why?
|
| Acetylation | 2 | 2007 | 12 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 104 | 0.130 |
Why?
|
| Reperfusion Injury | 1 | 1997 | 3 | 0.130 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 1997 | 7 | 0.130 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 124 | 0.130 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 227 | 0.130 |
Why?
|
| Sex Factors | 2 | 2010 | 384 | 0.130 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 32 | 0.130 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2016 | 2 | 0.130 |
Why?
|
| Sphingomyelins | 3 | 2009 | 5 | 0.130 |
Why?
|
| Culture Media, Conditioned | 2 | 2013 | 16 | 0.130 |
Why?
|
| Models, Molecular | 1 | 2016 | 70 | 0.120 |
Why?
|
| Chondrodysplasia Punctata, Rhizomelic | 1 | 1996 | 1 | 0.120 |
Why?
|
| Cyclic GMP | 2 | 2006 | 3 | 0.120 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 52 | 0.120 |
Why?
|
| Amino Acid Sequence | 2 | 2016 | 145 | 0.120 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 80 | 0.120 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2016 | 2 | 0.120 |
Why?
|
| Poly I-C | 2 | 2007 | 5 | 0.120 |
Why?
|
| Pregnancy | 2 | 2007 | 324 | 0.120 |
Why?
|
| Epoxide Hydrolases | 1 | 1996 | 8 | 0.120 |
Why?
|
| Ketoconazole | 1 | 1995 | 5 | 0.120 |
Why?
|
| Mercuric Chloride | 1 | 1995 | 1 | 0.120 |
Why?
|
| Fresh Water | 1 | 1995 | 4 | 0.120 |
Why?
|
| DNA, Complementary | 2 | 2008 | 22 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 39 | 0.120 |
Why?
|
| Depression | 1 | 2018 | 368 | 0.120 |
Why?
|
| Growth Inhibitors | 2 | 2007 | 11 | 0.120 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 19 | 0.120 |
Why?
|
| Proteolysis | 1 | 2015 | 6 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2007 | 17 | 0.120 |
Why?
|
| Pyrimidines | 1 | 2015 | 24 | 0.120 |
Why?
|
| Intracellular Membranes | 1 | 1995 | 19 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 66 | 0.120 |
Why?
|
| CCAAT-Binding Factor | 1 | 2015 | 2 | 0.110 |
Why?
|
| Lipids | 2 | 2006 | 44 | 0.110 |
Why?
|
| Tretinoin | 1 | 2015 | 15 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 19 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 21 | 0.110 |
Why?
|
| Mitochondria, Liver | 1 | 1994 | 2 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2015 | 16 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 164 | 0.110 |
Why?
|
| Autophagy | 1 | 2015 | 28 | 0.110 |
Why?
|
| Powders | 1 | 2014 | 2 | 0.110 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 3 | 0.110 |
Why?
|
| Amyloid | 1 | 2014 | 37 | 0.110 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2014 | 4 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 11 | 0.110 |
Why?
|
| Child | 1 | 2017 | 1153 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2013 | 37 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1993 | 12 | 0.100 |
Why?
|
| RNA Interference | 1 | 2013 | 34 | 0.100 |
Why?
|
| Formates | 1 | 2013 | 1 | 0.100 |
Why?
|
| Cell Shape | 1 | 2013 | 6 | 0.100 |
Why?
|
| Hormone Replacement Therapy | 1 | 2013 | 31 | 0.100 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2013 | 9 | 0.100 |
Why?
|
| Microtubules | 1 | 2013 | 26 | 0.100 |
Why?
|
| Drug Resistance, Microbial | 5 | 1997 | 66 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 28 | 0.100 |
Why?
|
| Axons | 1 | 2013 | 24 | 0.100 |
Why?
|
| Diacylglycerol Kinase | 2 | 2004 | 4 | 0.100 |
Why?
|
| Binding Sites | 2 | 2007 | 60 | 0.100 |
Why?
|
| Protein Kinase C | 1 | 2013 | 47 | 0.100 |
Why?
|
| Drug Interactions | 2 | 2006 | 35 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2013 | 51 | 0.100 |
Why?
|
| Incidence | 1 | 2015 | 624 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 36 | 0.100 |
Why?
|
| Shock, Hemorrhagic | 1 | 2012 | 1 | 0.100 |
Why?
|
| Splanchnic Nerves | 1 | 2012 | 1 | 0.100 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2012 | 1 | 0.100 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2012 | 3 | 0.100 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2012 | 3 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 4 | 2002 | 119 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 2 | 0.090 |
Why?
|
| Sympathetic Nervous System | 1 | 2012 | 13 | 0.090 |
Why?
|
| I-kappa B Kinase | 1 | 2012 | 4 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 10 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2012 | 53 | 0.090 |
Why?
|
| Merbromin | 1 | 1992 | 1 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2007 | 795 | 0.090 |
Why?
|
| Fluoresceins | 1 | 1992 | 5 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 183 | 0.090 |
Why?
|
| Phenylmercuric Acetate | 1 | 1991 | 1 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 46 | 0.090 |
Why?
|
| Pain | 1 | 2013 | 326 | 0.090 |
Why?
|
| Blotting, Northern | 2 | 2001 | 18 | 0.080 |
Why?
|
| Gliosis | 1 | 2010 | 6 | 0.080 |
Why?
|
| Flavonoids | 2 | 2002 | 14 | 0.080 |
Why?
|
| Dihydrotestosterone | 1 | 2010 | 1 | 0.080 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2010 | 1 | 0.080 |
Why?
|
| Progesterone | 1 | 2010 | 19 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2010 | 12 | 0.080 |
Why?
|
| Estrogens | 1 | 2010 | 26 | 0.080 |
Why?
|
| Flavins | 1 | 1990 | 1 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2004 | 153 | 0.080 |
Why?
|
| Osteoarthritis | 1 | 2013 | 271 | 0.080 |
Why?
|
| Chromones | 2 | 2000 | 9 | 0.080 |
Why?
|
| Morpholines | 2 | 2000 | 14 | 0.080 |
Why?
|
| Kinetics | 4 | 2000 | 170 | 0.080 |
Why?
|
| Pravastatin | 1 | 2009 | 8 | 0.080 |
Why?
|
| Cattle | 1 | 2010 | 110 | 0.080 |
Why?
|
| Cricetulus | 1 | 2009 | 10 | 0.080 |
Why?
|
| CHO Cells | 1 | 2009 | 11 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2009 | 13 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2010 | 41 | 0.080 |
Why?
|
| Serum Albumin | 1 | 2009 | 21 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 33 | 0.080 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 11 | 0.080 |
Why?
|
| Neocortex | 1 | 2009 | 22 | 0.080 |
Why?
|
| Zellweger Syndrome | 4 | 1998 | 4 | 0.080 |
Why?
|
| Antigen Presentation | 1 | 2009 | 14 | 0.080 |
Why?
|
| Knee Joint | 1 | 2013 | 566 | 0.080 |
Why?
|
| Genetic Linkage | 3 | 1998 | 30 | 0.080 |
Why?
|
| Biodegradation, Environmental | 3 | 1995 | 4 | 0.080 |
Why?
|
| Neurotoxins | 1 | 2009 | 13 | 0.070 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 8 | 0.070 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 4 | 0.070 |
Why?
|
| Catalysis | 2 | 2000 | 16 | 0.070 |
Why?
|
| Triglycerides | 1 | 2009 | 54 | 0.070 |
Why?
|
| Catalase | 3 | 1998 | 5 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 56 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 108 | 0.070 |
Why?
|
| Colforsin | 2 | 1998 | 12 | 0.070 |
Why?
|
| Mesencephalon | 1 | 2007 | 21 | 0.070 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2007 | 4 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 1998 | 57 | 0.070 |
Why?
|
| Prions | 1 | 2007 | 6 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2013 | 364 | 0.070 |
Why?
|
| GATA3 Transcription Factor | 1 | 2007 | 3 | 0.070 |
Why?
|
| Injections, Subcutaneous | 1 | 2007 | 21 | 0.070 |
Why?
|
| Interleukin-4 | 1 | 2007 | 17 | 0.070 |
Why?
|
| Cognitive Dysfunction | 1 | 2015 | 737 | 0.070 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2007 | 4 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2007 | 25 | 0.070 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2007 | 10 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2007 | 66 | 0.070 |
Why?
|
| Arginine | 2 | 1998 | 17 | 0.060 |
Why?
|
| Subcellular Fractions | 3 | 1997 | 16 | 0.060 |
Why?
|
| Hydroxylation | 2 | 1997 | 2 | 0.060 |
Why?
|
| Cyclic N-Oxides | 1 | 2006 | 1 | 0.060 |
Why?
|
| Tetrazolium Salts | 1 | 2006 | 2 | 0.060 |
Why?
|
| Thionucleotides | 1 | 2006 | 4 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2006 | 2 | 0.060 |
Why?
|
| Thiazoles | 1 | 2006 | 15 | 0.060 |
Why?
|
| Viruses | 1 | 2006 | 5 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2006 | 17 | 0.060 |
Why?
|
| Lysine | 1 | 2006 | 13 | 0.060 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2006 | 1 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2006 | 41 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2006 | 6 | 0.060 |
Why?
|
| Oxazines | 1 | 2006 | 5 | 0.060 |
Why?
|
| Oxadiazoles | 1 | 2006 | 7 | 0.060 |
Why?
|
| Homeostasis | 1 | 2006 | 64 | 0.060 |
Why?
|
| Myelin Proteins | 1 | 2005 | 2 | 0.060 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2005 | 2 | 0.060 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2005 | 2 | 0.060 |
Why?
|
| Proline | 1 | 2005 | 10 | 0.060 |
Why?
|
| Oxidants | 1 | 2005 | 27 | 0.060 |
Why?
|
| RNA | 1 | 2005 | 29 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 54 | 0.060 |
Why?
|
| Organelles | 2 | 1997 | 4 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2005 | 69 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 103 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 10 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 1 | 2005 | 14 | 0.060 |
Why?
|
| Osteoporosis | 1 | 2006 | 73 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2005 | 84 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2004 | 4 | 0.060 |
Why?
|
| Receptors, CXCR4 | 1 | 2004 | 17 | 0.060 |
Why?
|
| Hypoxanthine | 1 | 2004 | 1 | 0.060 |
Why?
|
| Xanthine Oxidase | 1 | 2004 | 2 | 0.060 |
Why?
|
| NADPH Dehydrogenase | 1 | 2004 | 5 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2004 | 9 | 0.060 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 10 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2004 | 23 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 38 | 0.050 |
Why?
|
| Bacterial Proteins | 2 | 2013 | 89 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 51 | 0.050 |
Why?
|
| Benzene | 2 | 1995 | 2 | 0.050 |
Why?
|
| Neoplasms | 1 | 2006 | 215 | 0.050 |
Why?
|
| Rats, Inbred Lew | 2 | 2000 | 9 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 7 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2003 | 71 | 0.050 |
Why?
|
| Interferon-beta | 1 | 2002 | 5 | 0.050 |
Why?
|
| Integrin alpha4 | 1 | 2002 | 3 | 0.050 |
Why?
|
| Cell Division | 1 | 2002 | 79 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2002 | 52 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 2 | 2018 | 25 | 0.040 |
Why?
|
| Neuritis | 1 | 2000 | 1 | 0.040 |
Why?
|
| Cell Compartmentation | 2 | 1998 | 8 | 0.040 |
Why?
|
| Lysosomal Storage Diseases | 1 | 1999 | 1 | 0.040 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1999 | 2 | 0.040 |
Why?
|
| Glomerular Mesangium | 1 | 1999 | 2 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2019 | 34 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 15 | 0.040 |
Why?
|
| Retina | 1 | 2018 | 8 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1998 | 2 | 0.040 |
Why?
|
| Protein Phosphatase 1 | 1 | 1998 | 2 | 0.040 |
Why?
|
| Okadaic Acid | 1 | 1998 | 5 | 0.040 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1998 | 2 | 0.040 |
Why?
|
| Rolipram | 1 | 1998 | 3 | 0.040 |
Why?
|
| Pyrrolidinones | 1 | 1998 | 4 | 0.040 |
Why?
|
| Nitrites | 1 | 1998 | 3 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 10 | 0.040 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 1997 | 1 | 0.030 |
Why?
|
| Nitric Acid | 1 | 1997 | 1 | 0.030 |
Why?
|
| Mitogens | 1 | 1997 | 5 | 0.030 |
Why?
|
| Sesquiterpenes | 1 | 1997 | 4 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 79 | 0.030 |
Why?
|
| Flavobacterium | 1 | 1997 | 1 | 0.030 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 1997 | 1 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 1997 | 29 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2016 | 2 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2016 | 10 | 0.030 |
Why?
|
| Membranes, Artificial | 1 | 2016 | 5 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 11 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 32 | 0.030 |
Why?
|
| Glutathione | 2 | 1998 | 19 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 1995 | 6 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1995 | 6 | 0.030 |
Why?
|
| Reference Values | 1 | 1996 | 169 | 0.030 |
Why?
|
| Dextrans | 1 | 1995 | 3 | 0.030 |
Why?
|
| Drug Synergism | 2 | 1998 | 38 | 0.030 |
Why?
|
| Fibric Acids | 1 | 1994 | 1 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme Inhibitors | 1 | 1994 | 1 | 0.030 |
Why?
|
| Carnitine | 1 | 1994 | 6 | 0.030 |
Why?
|
| Posterior Horn Cells | 1 | 2013 | 3 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2013 | 50 | 0.030 |
Why?
|
| Iohexol | 1 | 1993 | 2 | 0.030 |
Why?
|
| Hyperalgesia | 1 | 2013 | 42 | 0.030 |
Why?
|
| Epithelium | 1 | 1993 | 26 | 0.030 |
Why?
|
| Perforin | 1 | 2013 | 2 | 0.020 |
Why?
|
| Granzymes | 1 | 2013 | 7 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 6 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 24 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 39 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 2012 | 4 | 0.020 |
Why?
|
| Sympathectomy | 1 | 2012 | 3 | 0.020 |
Why?
|
| Adrenal Medulla | 1 | 2012 | 7 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2012 | 14 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 103 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2012 | 166 | 0.020 |
Why?
|
| Volatilization | 1 | 1991 | 4 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 283 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1991 | 52 | 0.020 |
Why?
|
| Glucose | 1 | 1991 | 43 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1990 | 8 | 0.020 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 2 | 1998 | 4 | 0.020 |
Why?
|
| Penicillamine | 2 | 1997 | 2 | 0.020 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 2 | 1997 | 2 | 0.020 |
Why?
|
| Palmitic Acid | 2 | 1996 | 4 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 103 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2002 | 36 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 228 | 0.010 |
Why?
|
| Amitrole | 1 | 1998 | 1 | 0.010 |
Why?
|
| Diamide | 1 | 1998 | 1 | 0.010 |
Why?
|
| Glutathione Disulfide | 1 | 1998 | 1 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 4 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 1998 | 2 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1998 | 5 | 0.010 |
Why?
|
| Glioma | 1 | 1998 | 16 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 4 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1998 | 33 | 0.010 |
Why?
|
| Peroxisome-Targeting Signal 1 Receptor | 1 | 1998 | 1 | 0.010 |
Why?
|
| Peroxisomal Targeting Signal 2 Receptor | 1 | 1998 | 1 | 0.010 |
Why?
|
| Plasmalogens | 1 | 1998 | 1 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 2 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1998 | 37 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1997 | 31 | 0.010 |
Why?
|
| Soil Pollutants | 1 | 1997 | 1 | 0.010 |
Why?
|
| Soil Microbiology | 1 | 1997 | 3 | 0.010 |
Why?
|
| Pesticide Residues | 1 | 1997 | 2 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1995 | 6 | 0.010 |
Why?
|
| Chondrodysplasia Punctata | 1 | 1993 | 1 | 0.010 |
Why?
|
| Epoxy Compounds | 1 | 1993 | 2 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1993 | 4 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1993 | 5 | 0.010 |
Why?
|
| Ferric Compounds | 1 | 1993 | 4 | 0.010 |
Why?
|
| Chlorides | 1 | 1993 | 24 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 1993 | 35 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1991 | 3 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1991 | 45 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1991 | 83 | 0.010 |
Why?
|